no statement of use filed
on 06 May 2024
Last Applicant/ Owned by
5555 OBERLIN DRIVE, SUITE 120
SAN DIEGO
CA
92121
Serial Number
97451225 filed on 09th Jun 2022
Registration Number
N/A
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Scientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development Read More
Scientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of DNA technology for purposes of providing gene therapy; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy
N/A
N/A
Pharmaceutical preparations for gene therapy to treat human diseases and disorders; gene therapy products, namely, pharmaceutical preparations to treat genetic disorders, namely, human diseases and disorders
N/A
N/A
No 97451225
No Service Mark
No 62600-TM1012
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th May 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
06th May 2024 | ABANDONMENT - NO USE STATEMENT FILED |
03rd Oct 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
08th Aug 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
08th Aug 2023 | PUBLISHED FOR OPPOSITION |
19th Jul 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
03rd Jul 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
30th Jun 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
29th Jun 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
29th Jun 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |